OHR Pharmaceutical Inc.

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
02/15/17 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 8
02/14/17 10-Q Quarterly report pursuant to Section 13 or 15(d)
Related Documents
44
02/14/17 8-K Current report filing
Related Documents
6
02/09/17 NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB 3
12/30/16 S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Related Documents
10
12/22/16 10-K Annual report pursuant to Section 13 and 15(d) 122
12/22/16 8-K Current report filing
Related Documents
10
12/15/16 8-K Current report filing
Related Documents
6
12/14/16 NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT 3
12/09/16 424B5 Prospectus filed pursuant to Rule 424(b)(5) 80